The technology in the third generation products is based on kaolin, an earthy white naturally occurring inert mineral that has been known for many years to have clotting properties to have clotting properties.
it causes blood to clot within the wound.
It causes blood to clot within the wound.
It causes blood to clot within the wound
It causes blood to clot within the wound.
It causes blood to clot within the wound
It causes blood to clot within the wound.
When it is not practical or feasible to apply the Combat Application Tourniquet (CAT)
Unroll the gauze and pack it in the wound while applying direct pressure.
Unroll the gauze and pack it in the wound while applying direct pressure.
It causes the blood to clot within the wound
Quikclot is a hemostatic clotting agent that assists in rapidly forming surface blood clots to slow or stop the loss of blood, thereby preserving blood pressure and keeping a victim from "bleeding out" before the arrival of emergency medical personnel. Medical authorities are divided on the appropriateness of Quikclot and similar products due to the tendency of such products to cause significant burns in the affected area. Generally, Quickclot should be applied in the form of a pressure dressing applied directly over the wound. This allows the hemostatic agent to contact the wound and begin the clotting process while simultaneously providing direct pressure. Early versions of Quikclot were granular and, when poured directly into a wound, tended to travel into veins and arteries and cause significant burning along the veins and arteries. Newer versions in the form of Quikclot Combat Gauze have largely mitigated these early problems.
Quickclot combat gauze is a sterile dressing that is ready-to-use from the package. It is a temporary means of controlling bleeding from a traumatic wound. One advantage is that it will not stick to the wound, so that any clotting stays in place when the bandage is removed. Kaolin is the active ingredient that decreases clotting time dramatically, and has been shown to allow earlier recovery in medical trials.